XML 24 R12.htm IDEA: XBRL DOCUMENT v3.19.1
Note 5 - Income Taxes
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
5
.
Income Taxes
 
Income tax benefit reconciled to tax calculated at statutory rates is as follows:
 
(In thousands)
 
201
8
   
201
7
 
Federal tax expense (benefit) on net income/loss at statutory rate
  $
686
    $
(855
)
Change in valuation allowance
   
(412
)    
(3,419
)
Basis difference related to investment in SAVSU
   
––
 
   
(110
)
Return to provision
   
52
     
(1,038
)
Federal rate change true-up
 
 
––
     
5,421
 
Stock compensation
   
(748
)
 
 
––
 
Book loss in SAVSU    
141
     
––
 
162(m) limitation on executive compensation deductibility
   
296
   
 
––
 
Other
   
(15
)    
1
 
Benefit (expense) for income taxes, net
 
$
––
   
$
––
 
 
At
December 
31,
2018
and
2017,
the components of the Company’s deferred taxes are as follows:
 
(In thousands)
 
201
8
   
201
7
 
Deferred tax assets (liabilities)
               
Net operating loss carryforwards
  $
7,381
    $
8,162
 
Accrued compensation
   
181
     
32
 
Depreciation
   
(24
)
   
43
 
Section 263a inventory adjustment
   
42
     
29
 
Stock-based compensation
   
664
     
688
 
Deferred rent
   
101
   
 
––
 
Outside basis difference in SAVSU
   
––
     
(225
)
Other
 
 
––
     
28
 
Total
   
8,345
     
8,757
 
Less: Valuation allowance
   
(8,345
)
   
(8,757
)
Net deferred tax asset
 
$
––
   
$
––
 
 
On
December 22, 2017,
“H.R.1”,
known as the “Tax Cuts and Jobs Act”, was signed into law in the United States. Among other items,
H.R.1
reduces the federal corporate tax rate to
21%
from the existing maximum rate of
35%,
effective
January 1, 2018.
As a result, the Company revalued its net deferred tax asset at the new lower tax rate during the year ended
December 31, 2017.
The Company has reduced the value of the deferred tax asset before valuation allowance by
$5.4
million at
December 31, 2017.
Based on our estimated
2018
pre-tax income of
$2.3
million, we reduced our usable net operating loss carryforwards by
$2.3
million.
 
The Company has the following net operating loss tax carryforwards available at
December 
31,
2018:
 
(In thousands)
Year of Expiration
 
Net Operating
Losses
 
 
2019
  $
259
 
 
2020
   
2,849
 
 
2021
   
4,168
 
 
2023
   
1,217
 
 
2024
   
646
 
 
2025
   
589
 
 
2026
   
873
 
 
2027
   
2,607
 
 
2028
   
2,512
 
 
2029
   
2,196
 
 
2030
   
1,232
 
 
2031
   
1,028
 
 
2032
   
437
 
 
2033
   
37
 
 
2034
   
6,409
 
 
2035
   
3,093
 
 
2036
   
4,995
 
 
Total
  $
35,147
 
 
Based on historical losses and potential future changes in the ownership of the Company, the utilization of such loss and tax credit carryforwards could be substantially limited.
 
We have recorded a full valuation allowance against our deferred tax assets. As we trend towards positive net income, we will continue to assess our valuation allowance. Based on all available evidence, we determined that we have
not
yet attained a sustained level of profitability. Therefore, we have maintained the full valuation allowance at
December 31, 2018.
We
may
release all, or a portion, of the valuation allowance in the near-term, dependent on the verifiable positive evidence observed in future years.